Total Payments
$282,032
2024 Payments
$9,217
Companies
17
Transactions
379
Medicare Patients
1,105
Medicare Billing
$95,266
Payment Breakdown by Category
Other$269,458 (95.5%)
Food & Beverage$10,392 (3.7%)
Travel$2,075 (0.7%)
Education$106.97 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $269,458 | 125 | 95.5% |
| Food and Beverage | $10,392 | 239 | 3.7% |
| Travel and Lodging | $2,075 | 9 | 0.7% |
| Education | $106.97 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $280,227 | 302 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $298.04 | 19 | $0 (2024) |
| Amgen Inc. | $236.31 | 12 | $0 (2023) |
| Abbott Laboratories | $230.42 | 8 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $211.85 | 6 | $0 (2022) |
| Medtronic, Inc. | $134.34 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $126.71 | 6 | $0 (2023) |
| PBG PUERTO RICO LLC | $125.18 | 7 | $0 (2021) |
| Janssen Biotech, Inc. | $108.54 | 2 | $0 (2024) |
| Boston Scientific Corporation | $106.64 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,217 | 11 | Janssen Pharmaceuticals, Inc ($9,069) |
| 2023 | $20,812 | 24 | Janssen Pharmaceuticals, Inc ($20,513) |
| 2022 | $43,009 | 44 | Janssen Pharmaceuticals, Inc ($42,842) |
| 2021 | $37,589 | 65 | Janssen Pharmaceuticals, Inc ($37,257) |
| 2020 | $31,367 | 40 | Janssen Pharmaceuticals, Inc ($31,186) |
| 2019 | $60,298 | 72 | Janssen Pharmaceuticals, Inc ($60,157) |
| 2018 | $45,301 | 65 | Janssen Pharmaceuticals, Inc ($44,990) |
| 2017 | $34,439 | 58 | Janssen Pharmaceuticals, Inc ($34,212) |
All Payment Transactions
379 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $93.54 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,399.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,399.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $80.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/02/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $52.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $78.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,030.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,030.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/29/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2023 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $134.34 | General |
| Category: Transcatheter Valve Systems | ||||||
| 10/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: DIABETES | ||||||
| 10/04/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/21/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $60.63 | General |
| Category: WATCHMAN_IC | ||||||
| 06/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: DIABETES | ||||||
| 05/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/29/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/29/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $80.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/16/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 254 | 551 | $34,970 | $22,426 |
| 2022 | 5 | 265 | 500 | $34,655 | $22,187 |
| 2021 | 5 | 282 | 591 | $41,521 | $26,786 |
| 2020 | 6 | 304 | 536 | $34,874 | $23,867 |
Total Patients
1,105
Total Services
2,178
Medicare Billing
$95,266
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 247 | $22,421 | $14,080 | 62.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 40 | 40 | $7,943 | $5,422 | 68.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 102 | 251 | $3,650 | $2,318 | 63.5% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 12 | 13 | $956.02 | $605.52 | 63.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 211 | $19,486 | $12,191 | 62.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 38 | 38 | $7,830 | $5,300 | 67.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 100 | 220 | $3,210 | $2,030 | 63.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 14 | 14 | $2,809 | $1,867 | 66.5% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2022 | 16 | 17 | $1,320 | $798.89 | 60.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 104 | 259 | $23,962 | $15,312 | 63.9% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 49 | 49 | $10,260 | $6,688 | 65.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 106 | 258 | $3,895 | $2,544 | 65.3% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 11 | 11 | $2,260 | $1,569 | 69.4% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg, includes recording, scanning analysis with report | Office | 2021 | 12 | 14 | $1,145 | $673.06 | 58.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 103 | 221 | $16,892 | $10,999 | 65.1% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 37 | 37 | $7,870 | $5,759 | 73.2% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2020 | 20 | 20 | $4,098 | $3,253 | 79.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 106 | 216 | $3,758 | $2,460 | 65.5% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg | Office | 2020 | 13 | 15 | $1,356 | $831.05 | 61.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 25 | 27 | $901.30 | $565.01 | 62.7% |
About Dr. Manuel Guzman, M.D
Dr. Manuel Guzman, M.D is a Cardiovascular Disease healthcare provider based in San Juan, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1891835427.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manuel Guzman, M.D has received a total of $282,032 in payments from pharmaceutical and medical device companies, with $9,217 received in 2024. These payments were reported across 379 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($269,458).
As a Medicare-enrolled provider, Guzman has provided services to 1,105 Medicare beneficiaries, totaling 2,178 services with total Medicare billing of $95,266. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location San Juan, PR
- Active Since 02/06/2007
- Last Updated 04/20/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891835427
Products in Payments
- XARELTO (Drug) $279,849
- ELIQUIS (Drug) $285.65
- INVOKANA (Drug) $282.35
- Repatha (Biological) $216.95
- FARXIGA (Drug) $139.36
- COREVALVE EVOLUT R (Device) $134.34
- BRILINTA (Drug) $121.82
- DARZALEX (Biological) $108.54
- WATCHMAN Access System (Device) $106.64
- JARDIANCE (Drug) $99.16
- ZYTIGA (Drug) $74.03
- Confirm Rx (Device) $49.73
- JANUVIA (Drug) $47.31
- CHANTIX (Drug) $41.19
- CRT-Ds (Device) $40.88
- Connectivity and Remote care (Device) $40.00
- LOKELMA (Drug) $36.86
- VYNDAQEL (Drug) $33.18
- Allure Quadra RF CRT Pacemaker (Device) $29.73
- LifeVest (Device) $25.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in San Juan
Damian Grovas-Abad, M.d, M.D
Cardiovascular Disease — Payments: $475,819
Cardiovascular Disease $475,819
Ramon Perea, M.d, M.D
Cardiovascular Disease — Payments: $105,606
Cardiovascular Disease $105,606
Dr. Sonia Velazquez-Navarro, M.d, M.D
Cardiovascular Disease — Payments: $65,245
Cardiovascular Disease $65,245
Dr. Teodosio Rucabado, M.d, M.D
Cardiovascular Disease — Payments: $42,707
Cardiovascular Disease $42,707
Dr. Luarde Montano-Soto, M.d, M.D
Cardiovascular Disease — Payments: $37,262
Cardiovascular Disease $37,262
Jose Kareh Cordero, M.d, M.D
Cardiovascular Disease — Payments: $24,128
Cardiovascular Disease $24,128